Biological Standarization of Cupressus Arizonica Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP)

Trial Profile

Biological Standarization of Cupressus Arizonica Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP)

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Jun 2016

At a glance

  • Drugs Cupressus arizonica pollen allergy immunotherapy-Laboratorios-Leti (Primary)
  • Indications Tree pollen hypersensitivity
  • Focus Diagnostic use
  • Sponsors Laboratorios LETI
  • Most Recent Events

    • 17 Jun 2016 Status changed from active, no longer recruiting to completed.
    • 15 Dec 2015 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
    • 13 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top